What is the APUS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Apimeds Pharmaceuticals US, Inc (APUS) price will be around $2.06 in the next 2 weeks. This means it will increase by 9.776595744680861 from the last closing price. This prediction may vary from other time period filters for APUS stock.

What can be the highest Possible price of APUS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, APUS can achieve the highest price of $2.26 which is 20.028526100716203 higher than last closing price. This prediction may vary from other time period filters for APUS stock.

What can be the lowest Possible price of APUS stock in next 2 weeks?

As per the forecast and algorithmic analysis, APUS stock price can be as low as $1.87 which is -0.5199329402908436 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for APUS stock.

Will APUS stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that APUS stock will gain9.776595744680861 in the next 2 weeks. This prediction may vary from other time period filters for APUS stock.

What is APUS stock last closing price?

Last closing price of APUS stock was $1.88.

What is APUS stock price prediction?

APUS stock price prediction means predicting the future closing prices of APUS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of APUS stock in a certain time period.

How we predict APUS stock future prices?

If you are searching for APUS stock forecast, analysis or price prediction, then you might be wondering what Apimeds Pharmaceuticals US, Inc (APUS) will do in the future. Our APUS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This APUS price prediction will likely answer most of your questions.

How frequent we update APUS stock predictions?

We are updating the forecasts for the APUS stock on daily basis.

Is using ML forecasting for APUS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for APUS stock same for all the time periods?

No, the prediction for APUS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Apimeds Pharmaceuticals US, Inc Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.880%Since 2 Weeks

Predicted Price$2.069.78%For 2 Weeks

Upper Predicted Price$2.2620.03%For 2 Weeks

Lower Predicted Price$1.87-0.52%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of APUS will rise by +9.78% over the next 2 Weeks and hit $2.06 by Monday, April 20, 2026. In that time frame, APUS's share price is expected to range between $1.87 and $2.26.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 20, 2026	1.85	2.05	2.22
Apr 17, 2026	1.91	2.11	2.32
Apr 16, 2026	1.89	2.08	2.27
Apr 15, 2026	1.82	2.02	2.22
Apr 14, 2026	1.80	1.98	2.17
Apr 13, 2026	1.77	1.96	2.14
Apr 10, 2026	1.82	2.02	2.20
Apr 9, 2026	1.80	1.99	2.18
Apr 8, 2026	1.74	1.93	2.11
Apr 7, 2026	1.71	1.89	2.08

APUS shares remained flat 0 in Monday, April 6, 2026's trading session, starting and closing at a previous close of $1.88 to move at $1.88. The stock demonstrated notable intraday movement (see APUS's key stats for a full breakdown), fluctuating between $1.69 and $1.89, a +11.83% trading range. While recent weeks have seen some volatility, APUS has managed to secure a -8.74% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 31.52K shares changing hands, 71 fewer than the previous session. This amounted to $59.26K in total market activity.

Will APUS Continue Its Upward Trend?

According to analyst ratings and projections for APUS, Apimeds Pharmaceuticals US, Inc shares are anticipated to increase by +15.41%, potentially reaching $2.22 per share by April 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for APUS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the APUS stock forecast, now is a good time to buy APUS stock because its current trading price is -8.19% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on APUS covering social and institutional perspectives.

APUS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into APUS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.64% to 58.96%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.23%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.88%, maintains a neutral outlook for the long term. Insights into APUS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Apimeds Pharmaceuticals US Short-Term Forecasts

APUS Forecast For Next 5 Days

Our algorithm anticipates Apimeds Pharmaceuticals US (APUS) stock could hit $1.50 by Apr 28, 2026. This represents a -20.36% fall from today's price, following a -10.16% change over the past five days.

APUS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Apimeds Pharmaceuticals US, Inc (APUS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.60, which would mean a -14.89% decrease from the current price of $1.88. Projections for this period range from a high of $2.12 to a low of $1.16.

APUS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Apimeds Pharmaceuticals US's price over the next three months point to a rise. APUS stock is expected to peak at $13.19 on May 18, 2026 before potentially dipping to $7.77 on Jun 25, 2026. On average, APUS is likely to trade around $9.84 in the coming 90 days.

Apimeds Pharmaceuticals US Stock Forecast 2025

Based on our predictive models, Apimeds Pharmaceuticals US (APUS) is expected to trade between $6.66 and $13.33 throughout 2026. This would result in an average price of $9.66, potentially offering investors a +413.83% return from current levels.

Apimeds Pharmaceuticals US, Inc Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Apimeds Pharmaceuticals US, Inc (APUS) is positioned to show a strong performance in April 2026. The price is predicted to move between $8.20 and $10.51, settling at an average of $9.15. This could translate to a +386.70% gain.

May 2026

Based on current market signals, Apimeds Pharmaceuticals US, Inc is projected to trend may 2026. We forecast a trading range from $10.28 to $13.19, with a likely average price of $11.89. Investors could expect a potential return of +532.45%.

June 2026

Our predictive algorithms indicate Apimeds Pharmaceuticals US, Inc stock may see a shift in June 2026. The expected range spans $7.77–$10.17, with an average target of $8.75. This represents a positive outlook and a possible gain of +365.43%.

July 2026

Analyzing established trends, Apimeds Pharmaceuticals US, Inc looks set to move in July 2026. Projections place the stock between $8.09 and $9.58, averaging around $8.86. This suggests a +371.28% gain from current levels.

August 2026

Market indicators suggest Apimeds Pharmaceuticals US, Inc could experience notable changes during August 2026. Prices could fluctuate within $7.83 to $10.11, with a midpoint forecast of $9.35. The stock might deliver a +397.34% gain.

September 2026

Forecasting for September 2026, models estimate that Apimeds Pharmaceuticals US, Inc may undergo key fluctuations. If trends hold, the stock might trade between $9.46 and $11.34, averaging $10.10. This signals a positive trajectory with potential returns around +437.23%.

October 2026

According to our latest forecast models, Apimeds Pharmaceuticals US, Inc (APUS) is positioned to show a strong performance in October 2026. The price is predicted to move between $7.25 and $11.01, settling at an average of $8.70. This could translate to a +362.77% gain.

November 2026

Based on current market signals, Apimeds Pharmaceuticals US, Inc is projected to trend november 2026. We forecast a trading range from $10.20 to $13.33, with a likely average price of $11.63. Investors could expect a potential return of +518.62%.

December 2026

Our predictive algorithms indicate Apimeds Pharmaceuticals US, Inc stock may see a shift in December 2026. The expected range spans $6.66–$10.17, with an average target of $8.42. This represents a positive outlook and a possible gain of +347.87%.

January 2027

Analyzing established trends, Apimeds Pharmaceuticals US, Inc looks set to move in January 2027. Projections place the stock between $6.94 and $9.73, averaging around $8.75. This suggests a +365.43% gain from current levels.

February 2027

Market indicators suggest Apimeds Pharmaceuticals US, Inc could experience notable changes during February 2027. Prices could fluctuate within $6.23 to $8.19, with a midpoint forecast of $7.38. The stock might deliver a +292.55% gain.

March 2027

Forecasting for March 2027, models estimate that Apimeds Pharmaceuticals US, Inc may undergo key fluctuations. If trends hold, the stock might trade between $6.36 and $8.46, averaging $7.17. This signals a positive trajectory with potential returns around +281.38%.

April 2027

According to our latest forecast models, Apimeds Pharmaceuticals US, Inc (APUS) is positioned to show a strong performance in April 2027. The price is predicted to move between $7.61 and $8.42, settling at an average of $8.04. This could translate to a +327.66% gain.

APUS's history of dividends and stock splits also plays a role in long-term investor confidence.